Apart from contributing to protecting the parasite against the defense mechanisms

of the host, many of them also appear to have the capacity to induce perturbations in the host physiology. Emricasan datasheet Given their abundance, one may speculate that they play a genuine role in the pathology. Some of these proteins may be promising candidates for diagnosis or therapy. As well as degrading proteins, proteases perform highly specific processing tasks that can affect protein structure, function, life span, and localization. By limited and specific cleavage, proteases can act as switches, turning protein activity on or off, or can modulate protein function in more complex ways, regulating vital processes. Indeed, more than 53 specific hereditary diseases of proteolysis are recognized and it is therefore not surprising that proteases are implicated in many pathologies. Hence, proteases account for 5-10% of drug targets, with protease inhibitor drugs already in use to treat AIDS (acquired immunodeficiency syndrome) by blocking HIV (human immunodeficiency virus) protease-1, cardiovascular disease by targeting angiotensin convertase enzyme and rennin, and multiple myeloma by the reversible covalent proteasome

inhibitor. In addition, many biomarkers of disease, especially in cancer, are stable fragments generated by proteolysis AP26113 manufacturer and found in biological fluids [52]. Enzymes of nucleotide metabolism are another major class of ESPs represented here by more than 46 protein accessions. This is not find more unexpected, as T. brucei is incapable of de novo purine nucleotide synthesis and expresses purine salvage enzymes to recover host purines [53]. However, extracellular nucleotides are also signaling molecules that modulate a wide variety of physiological responses in mammalian tissues [54] Rebamipide and are archetypal activators of the innate immune system [55]. In this context, both hematophagous insects and endoparasites secrete enzymes degrading nucleotides, thus minimizing inflammatory reactions or purinergic signaling provoked by these mediators [56, 57]. As such, the identification of several nucleotide-metabolizing enzymes

in the secretome raises the question of whether T. brucei might exploit such strategies to modulate the concentration of extracellular nucleotides, hence affecting a range of inflammatory responses. If so, Trypanosoma would not only divert the host nucleotides for its own requirements, but also to evade an immune response. Enzymes involved in glycolysis and carbohydrate metabolism are not a major class of the secretome, but this category still numbers more than 36 accessions. Trypanosoma have a simplified energy metabolism entirely dependent on external carbohydrate sources, such as blood glucose. Most glycolysis enzymes are compartmented in glycosomes [58], but three are cytosolic: phosphoglycerate mutase, enolase, and pyruvate kinase [59]. We found all three in the T.